Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of ...

Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...

Several companies have pitched the idea of marketing implantable blood sugar measuring devices to people without diabetes.

Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device to empower people in ...

Intermittent fasting is an effective method for weight loss and enhances cardiovascular health in individuals with obesity. A ...

LOVE Island star Marcel Somerville has sparked curiosity among All Stars viewers thanks to a small white patch often seen on ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Dexcom (DXCM – Research Report) on January 13 and set a price target of ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

Czech National Bank grew its position in Insulet Co. (NASDAQ:PODD – Free Report) by 6.5% during the fourth quarter, according ...

HYDERABAD: Startup around a decade ago, this word was still relatively new lingo in Hyderabad. But today, everywhere we look, startups are sprouting and bloomin ...

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, is recognizing a critical milestone ...